(Q45717861)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

editorial

0 references

title

Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Ricardo P Garay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Raafat El-Gewely

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jonathan K Armstrong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

George Garratty

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

30 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Delivery

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

1319-1323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22931049%20AND%20SRC:MED&resulttype=core&format=json

Product development issues for PEGylated proteins

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

21 January 2018

Emerging PEGylated drugs

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Enhanced gene delivery using Bubble liposomes and ultrasound for folate-PEG liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Modulating antibody pharmacokinetics using hydrophilic polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Therapeutic perspectives on uricases for gout.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

PEG-uricase in the management of treatment-resistant gout and hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Biochemical and biopharmaceutical properties of PEGylated uricase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Characterization, stabilization and activity of uricase loaded in lipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Urate oxidase: primary structure and evolutionary implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

How to predict and prevent the immunogenicity of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Covalent binding of poly(ethylene glycol) (PEG) to the surface of red blood cells inhibits aggregation and reduces low shear blood viscosity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Role of the methoxy group in immune responses to mPEG-protein conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Gcg-XTEN: an improved glucagon capable of preventing hypoglycemia without increasing baseline blood glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969

Strategies for extended serum half-life of protein therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.720969